Skip to main content
Clinical Trials/NCT02384291
NCT02384291UnknownNot Applicable

Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone Versus Commercially Available Bone Graft. A Prospective Randomized Clinical Trial

Alpha - Bio Tec Ltd.0 sites44 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
44
Primary Endpoint
Histological bone formation following sinus floor augmentation [ evaluated by biopsies harvested from the implant sites]

Study Overview

Brief Summary

This clinical study is designed to compare the regenerative outcome of using separately two different Xenografts during sinus floor augmentation.

Aim of this prospective randomized-controlled clinical trial is to compare the regenerative results of Alpha-Bio's GRAFT Natural Bovine Bone versus commercially available bone graft after two-step sinus floor elevations by clinical and histological analysis.

Clinical Parameters are wound healing parameters, radiological volume stability and implant survival rates. Histological parameters are based on a histomorphometrical analysis of trephine cores harvested in progress of implant bed preparation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who will present with a moderately or severely atrophic posterior maxilla with 1-6 mm residual alveolar bone will be selected for the study.
  • •Men and women over the age of 18 years.
  • •Patient has signed the Informed Consent.

Exclusion Criteria

  • •Chronic steroid therapy,
  • •Uncontrolled diabetes,
  • •Cardiovascular disease,
  • •Past irradiation of head and neck
  • •Maxillary sinus cysts,
  • •Active chronic sinusitis,
  • •Smoking more than ten cigarettes per day during the 3 months preceding this study .
  • •Malignant disease in the 5 years preceding this study
  • •Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia
  • •Disease that compromise the immune system
  • •Psychiatric disorder
  • •Hypersensitivity to titanium, collagen or bovine bone.
  • •Women who are pregnant or nursing.
  • •Patients with non-treated periodontal disease.
  • •Medical and/or general contraindications for intraoral surgical procedures

Arms & Interventions

Alpha-Bios GRAFT Natural Bovine Bone treatment

Experimental

Pure Hydroxyapatite ceramic mineral with high similarity to the human bone

Intervention: Alpha-Bio GRAFT Natural Bovine Bone (Device)

natural bone substitute

Active Comparator

natural bone substitute material derived from the mineral portion of bovine bone

Intervention: natural bone substitute (Device)

Outcomes

Primary Outcomes

Histological bone formation following sinus floor augmentation [ evaluated by biopsies harvested from the implant sites]

Time Frame: 6 months

Secondary Outcomes

  • Bone volume-stable results six months following augmentation procedures [ demonstrated by X-ray evaluation].(6 months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials